CH583734A5 - - Google Patents

Info

Publication number
CH583734A5
CH583734A5 CH1552773A CH1552773A CH583734A5 CH 583734 A5 CH583734 A5 CH 583734A5 CH 1552773 A CH1552773 A CH 1552773A CH 1552773 A CH1552773 A CH 1552773A CH 583734 A5 CH583734 A5 CH 583734A5
Authority
CH
Switzerland
Application number
CH1552773A
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH583734A5 publication Critical patent/CH583734A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1552773A 1972-11-06 1973-11-05 CH583734A5 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5105072A GB1445983A (en) 1972-11-06 1972-11-06 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
CH583734A5 true CH583734A5 (hr) 1977-01-14

Family

ID=10458450

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1552773A CH583734A5 (hr) 1972-11-06 1973-11-05

Country Status (14)

Country Link
JP (1) JPS577127B2 (hr)
AU (1) AU467532B2 (hr)
BE (1) BE806946A (hr)
CA (1) CA975297A (hr)
CH (1) CH583734A5 (hr)
CY (1) CY940A (hr)
DE (1) DE2355204A1 (hr)
FR (1) FR2205309B1 (hr)
GB (1) GB1445983A (hr)
HK (1) HK1278A (hr)
IL (1) IL43562A (hr)
KE (1) KE2807A (hr)
MY (1) MY7800180A (hr)
ZA (1) ZA738489B (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499672A (en) * 1974-02-14 1978-02-01 Wellcome Found Tablet formulation
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
FR2608045B1 (fr) * 1986-12-12 1990-03-02 Chauvin Laboratoires Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors

Also Published As

Publication number Publication date
CY940A (en) 1978-06-23
AU467532B2 (en) 1975-12-04
IL43562A0 (en) 1974-03-14
DE2355204A1 (de) 1974-05-16
IL43562A (en) 1976-08-31
GB1445983A (en) 1976-08-11
FR2205309A1 (hr) 1974-05-31
BE806946A (fr) 1974-05-06
CA975297A (en) 1975-09-30
JPS49133517A (hr) 1974-12-21
MY7800180A (en) 1978-12-31
JPS577127B2 (hr) 1982-02-09
FR2205309B1 (hr) 1976-04-09
ZA738489B (en) 1975-02-26
AU6217773A (en) 1975-05-08
KE2807A (en) 1978-02-17
HK1278A (en) 1978-01-13

Similar Documents

Publication Publication Date Title
FR2175922B1 (hr)
JPS49133928A (hr)
FR2211745A1 (hr)
FR2209579A1 (hr)
JPS4958960A (hr)
FR2178430A5 (hr)
JPS5241093Y2 (hr)
JPS5145303Y2 (hr)
JPS5729949B2 (hr)
JPS4971224A (hr)
JPS492012U (hr)
JPS4919762U (hr)
CH577227A5 (hr)
CH575470A5 (hr)
CH581622A5 (hr)
CH581095A5 (hr)
CH581071A5 (hr)
CH580570A5 (hr)
CH578838A5 (hr)
CH578599A5 (hr)
CH578587A5 (hr)
CH578485A5 (hr)
CH578037A5 (hr)
CH577709A5 (hr)
CH572351A5 (hr)

Legal Events

Date Code Title Description
PL Patent ceased